NEW YORK and LONDON, Aug. 1, 2023 — KX, a global pioneer in vector native real time and high-volume time series data analytics, today unveiled the Early Access Program for KDB.AI, a multi-model vector ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...